A Small-molecule Carbonic Anhydrase IX Targeting PET Tracer in Clear Cell Renal Cell Carcinoma
Status:
Completed
Trial end date:
2022-03-04
Target enrollment:
Participant gender:
Summary
The goal of this pilot clinical trial is to see the potential application of a CAIX targeted
PET. tracer in patients with clear cell renal cell carcinoma. The main question[s] it aims to
answer are:
- The biodistribution of the PET tracer
- Whether RCC lesions can be identified by the PET tracer Participants will undergo
68Ga-NY104 PET/CT scan and images will be reviewed by nuclear medicine specialists.